What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will the industry target its efforts? Will the battles take place at the state level? Tune in to this Facebook Live as KHN senior correspondent Jay Hancock discusses these issues.
Circadian rhythms could hold the key to novel therapies for glioblastoma, the most prevalent type of brain cancer in adults—and one with a grim prognosis.
Taking a medication that builds bone mass followed by one that maintains it can significantly reduce the risk of fracture among post-menopausal women with severe osteoporosis, according to the results of a clinical trial.
Fifty-one years ago in San Francisco, a small community clinic opened its doors. Its mission: to treat many of the young people who flocked to the city — who were often homeless, hungry and sick. The Haight Ashbury Free Clinic, now part of a larger network, still operates out of a second-floor office overlooking Haight Street in San Francisco, and it still helps people on the fringes of society.
Researchers have developed a new way to attack cancer: using a non-toxic dose of sodium formate—found in nettles and ants—to trigger an organic-osmium compound.